Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,770,955
-$3,089,371 QoQ
Shares Held
877,627
+1.3% QoQ
Ownership
0.831%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. SRPT ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,770,955 | 877,627 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,860,326 | 866,743 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,691,113 | 264,457 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,136,649 | 266,562 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,015,250 | 234,810 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,291,790 | 208,270 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,403,375 | 151,356 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $17,842,034 | 142,862 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $21,989,018 | 139,171 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $11,506,663 | 88,882 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $8,497,893 | 88,125 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $11,217,819 | 92,541 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,441,589 | 91,177 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,755,984 | 99,804 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,502,069 | 81,047 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,614,824 | 77,934 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,893,395 | 91,961 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $7,175,399 | 91,851 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,837,501 | 87,035 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,969,740 | 86,178 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,607,565 | 226,493 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $30,807,942 | 413,363 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $69,279,633 | 406,356 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $57,384,050 | 408,631 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $42,075,138 | 262,412 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,567,296 | 251,148 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||